Lataa...
Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment
We previously identified an extracellular matrix (ECM) gene expression pattern in breast cancer (BC), called ECM3, characterized by a high expression of genes encoding structural ECM proteins. Since ECM is reportedly implicated in response to therapy of BCs, the aim of this work is to investigate th...
Tallennettuna:
| Julkaisussa: | Cells |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072535/ https://ncbi.nlm.nih.gov/pubmed/32069815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9020434 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|